Next Article in Journal
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
Next Article in Special Issue
Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
Previous Article in Journal
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
Previous Article in Special Issue
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Article

Article Versions Notes

Int. J. Mol. Sci. 2019, 20(16), 3935; https://doi.org/10.3390/ijms20163935
Action Date Notes Link
article html file updated 30 August 2025 23:52 CEST Update https://www.mdpi.com/1422-0067/20/16/3935/html
article html file updated 21 August 2025 22:04 CEST Update -
article html file updated 20 July 2022 05:20 CEST Update -
article html file updated 13 February 2020 09:24 CET Update -
article html file updated 15 August 2019 12:02 CEST Update -
article pdf uploaded. 15 August 2019 12:00 CEST Updated version of record https://www.mdpi.com/1422-0067/20/16/3935/pdf
article xml uploaded. 15 August 2019 12:00 CEST Update https://www.mdpi.com/1422-0067/20/16/3935/xml
article xml file uploaded 15 August 2019 12:00 CEST Update -
article html file updated 13 August 2019 10:04 CEST Original file -
article pdf uploaded. 13 August 2019 10:02 CEST Version of Record https://www.mdpi.com/1422-0067/20/16/3935/pdf-vor
article xml uploaded. 13 August 2019 10:02 CEST Update -
article xml file uploaded 13 August 2019 10:02 CEST Original file -
Back to TopTop